OptiMized REsistaNt Starch in Inflammatory Bowel Disease: the MEND Trial

NAActive, not recruitingINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

March 3, 2021

Primary Completion Date

September 30, 2025

Study Completion Date

December 31, 2025

Conditions

Crohn DiseaseUlcerative ColitisInflammatory Bowel Diseases

Interventions

OTHER

Resistant Starch

7.5 g resistant starch/m2 oral consumption

OTHER

Placebo

Placebo oral consumption of food-grade cornstarch

Trial Locations (1)

Children's Hospital of Eastern Ontario, Ottawa

All Listed Sponsors

lead

Children's Hospital of Eastern Ontario

OTHER